Efficacy of Phosphatidylinositol-3 Kinase Inhibitors in a Primary Mouse Model of Undifferentiated Pleomorphic Sarcoma

Table 1

Response rates of BKM120-treated tumors.

	Tumor response rate
	Complete	Partial	All  responders
BKM120	0/10	5/10	5/10 (50%)
BKM120+Dox	0/10	6/10	6/10 (60%)
Total	0/20	11/20	11/20 (55%)